WHO WE ARE
As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Code of conduct Global presence
OUR FOCUS
Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

PHARMACOSMOS LAUNCHES NEW WEBSITE ON NOVEL CRYOPROTECTANT PENTAISOMALTOSE®

Corporate News and Press Releases

Date02.08.2024

As a step towards the commercialisation of the novel DMSO-free cryoprotectant Pentaisomaltose® the website www.pentaisomaltose.com has been launched. Pharmacosmos is actively seeking clients, distributors and partners to join in the establishment of Pentaisomaltose® as the new golden standard for cryopreservation of selected cell types for clinical use.

Go to News & Press